Thomas J. George

13.4k citations

415 papers · 7.4k indexed · 2 hit papers · h-index 40

Impact in

Finance top 0.5%
- Financial Markets and Investment Strategies
Oncology top 1%
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Surgical Treatments
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers

Papers in

Oncology 221
- Colorectal Cancer Treatments and Studies 89
- Pancreatic and Hepatic Oncology Research 53
- Colorectal Cancer Surgical Treatments 46
Cancer Research 58
- Cancer Genomics and Diagnostics 51

Co-authors: Chuan-Yang Hwang Mahendrarajah Nimalendran Gautam Kaul Carmen J. Allegra Z. Hugh Fan Jason S. Starr Greg Yothers Chen Liu
Journals: Journal of Clinical Oncology (103 papers)The Journal of Organic Chemistry (8 papers)Cancer Research (7 papers)Cancer Medicine (7 papers)The Oncologist (7 papers)
Partner nations: United States India Canada

In The Last Decade

Thomas J. George

383 papers receiving 7.2k citations

Hit Papers

align trajectories log scale

Adjuvant Therapy for Stage II Colon Cancer: ASCO Guideline Update 2021 · 155 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2021 Journal of Clinical Oncology
2004 The Journal of Finance

Peers

Countries citing papers authored by Thomas J. George

Since Specialization

Citations

This map shows the geographic impact of Thomas J. George's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas J. George with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas J. George more than expected).

Fields of papers citing papers by Thomas J. George

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas J. George. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas J. George. The network helps show where Thomas J. George may publish in the future.

Co-authors

The 25 scholars most cited alongside Thomas J. George, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas J. George Line = papers co-authored together Thomas J. George links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Impact of Pre-Existing Frailty on Cardiotoxicity Among Breast Cancer Patients Receiving Adjuvant Therapy JACC CardioOncology ·Shuang Yang, Xiwei Lou, Mustafa M. Ahmed, Stephen E. Kimmel, Karen Daily, Thomas J. George, Carl J. Pepine, Jiang Bian, Dejana Braithwaite, Dongyu Zhang, Yi Guo	2025	1
2	Select updates from ASCO and ESMO 2024 for gastrointestinal cancer care The Oncologist ·Tim Jang, George P. Kim, Thomas J. George	2025	1
3	When remote work works better: How fit and autonomy shape employee outcomes Organizational Dynamics ·Thomas J. George, Dustin Maneethai, Leanne Atwater, Juan M. Madera	2025	0
4	Predicting Early-Onset Colorectal Cancer in Individuals Below Screening Age Using Machine Learning and Real-World Data: Case Control Study JMIR Cancer ·Chengkun Sun, Erin M. Mobley, Michael B. Quillen, Max Parker, Meghan Daly, Rui Wang, Isabela Visintin, Ziad T. Awad, Jennifer N. Fishe, Alexander S. Parker, Thomas J. George, Jiang Bian, Jie Xu	2025	0
5	AMPLIFY-7P, a first-in-human safety and efficacy trial of adjuvant mKRAS-specific lymph node targeted amphiphile ELI-002 7P vaccine in patients with minimal residual disease–positive pancreatic and colorectal cancer. Journal of Clinical Oncology ·Craig Devoe, Shubham Pant, Zev A. Wainberg, Vincent Chung, Thomas J. George, Pashtoon Murtaza Kasi, Haley VanWyk, Amy Tavares, James Perry, Thian Kheoh, Lisa K. McNeil, Esther Welkowsky, Peter C. DeMuth, Christopher M. Haqq, Eileen M. O’Reilly	2024	9
6	Implementation of a pharmacogenetic panel‐based test for pharmacotherapy‐based supportive care in an adult oncology clinic Clinical and Translational Science ·Emily J. Cicali, Elizabeth M. Eddy, Yan Gong, Amanda L. Elchynski, Kim Pena del Aguila, Tala Basha, Karen Daily, Lauren Dickson, Steven M. Fischer, Erin Hastings‐Monari, Dennie V. Jones, Brian Hemendra Ramnaraign, David L. DeRemer, Thomas J. George, Rhonda M. Cooper‐DeHoff	2024	1
7	A phase 2 clinical trial of first-in-class fascin inhibitor NP-G2-044 as monotherapy and in combination therapy with anti-PD-1 immunotherapy in patients with advanced solid tumor malignancies. Journal of Clinical Oncology ·Frank Tsai, Michael J. Birrer, Jason R. Brown, Sanjay Chandrasekaran, Vincent Chung, Richard C. Frank, Edward G. Garmey, Shirish M. Gadgeel, Thomas J. George, Shadia I. Jalal, Andrew Poklepovic, Jennifer Segar, Alexander I. Spira, Jue Jillian Zhang, Anup Kasi	2024	2
8	NSABP C-14/Exact Sciences 16-002: CORRECT-MRD II—Second colorectal cancer clinical validation study to predict recurrence using a circulating tumor DNA assay to detect minimal residual disease. Journal of Clinical Oncology ·Mohamed E. Salem, Shannon L. Puhalla, Thomas J. George, Carmen J. Allegra, Bradley A. Arrick, Melanie R. Palomares, Ki Y. Chung, Asheesh Shipstone, Michael Joseph McCormack, Frederick L. Baehner, Norman Wolmark	2024	0
9	Novel RNA-nanoparticle vaccine for the treatment of early melanoma recurrence following adjuvant anti-PD-1 antibody therapy. Journal of Clinical Oncology ·Bently P. Doonan, Shawna C. Willey, Ji‐Hyun Lee, Eugenio Simon Manso, Héctor Méndez-Gómez, Christina A. Von Roemeling, Duane A. Mitchell, Elias Sayour, Thomas J. George	2024	2
10	Gold Nanoparticle-Based Microfluidic Chips for Capture and Detection of Circulating Tumor Cells Biosensors ·Valber A. Pedrosa, Kangfu Chen, Thomas J. George, Z. Hugh Fan	2023	4
11	Importance of carbohydrate antigen (CA 19-9) and carcinoembrionic antigen (CEA) in the prognosis of patients with duodenal adenocarcinoma: a retrospective single-institution cohort study Oncotarget ·Ellery Altshuler, Raymond Richhart, William King, Mahmoud Aryan, Akash Mathavan, Akshay Mathavan, Keegan M. Hones, Daniel Leech, Logan Pucci, Joshua Riklan, Pat Haley, İlyas Şahin, Brian Hemendra Ramnaraign, Sherise C. Rogers, Ibrahim Nassour, Steven J. Hughes, Thomas J. George, Jesus C. Fabregas	2023	0
12	597P Surgical quality for patients (pts) treated with neoadjuvant chemotherapy vs chemoradiation for locally advanced rectal cancer (LARC): PROSPECT (NCCTG N1048, alliance) Annals of Oncology ·Martin R. Weiser, Qian Shi, George J. Chang, Lynn Hakki, Joel E. Goldberg, Rebecca C. Auer, Marc J. Gollub, Leonard B. Saltz, Benjamin Musher, Tareq Al Baghdadi, Jeffrey M. Farma, Thomas J. George, B. Colgrove, Garth D. Nelson, Eileen M. O’Reilly, Ardaman Shergill, Jeffrey A. Meyerhardt, Harvey J. Mamon, Deborah Schrag	2023	1
13	National adoption of neoadjuvant chemotherapy: paradigm shift in the treatment of pancreatic cancer HPB ·Ibrahim Nassour, Austin Parrish, Lucy Baptist, Sarah Voskamp, K. L. HANDOO, Sherise C. Rogers, Jesus C. Fabregas, Thomas J. George, Kathryn Hitchcock, Alessandro Paniccia, Steven J. Hughes	2023	12
14	A phase I, open-label study evaluating the safety and pharmacokinetics of trifluridine/tipiracil in patients with advanced solid tumors and varying degrees of renal impairment Cancer Chemotherapy and Pharmacology ·Muhammad Wasif Saif, Carlos Becerra, Marwan Fakih, Weijing Sun, Lazar Popović, Smitha Krishnamurthi, Thomas J. George, Michelle A. Rudek, Dale R. Shepard, Jiří Škopek, Vladimír Šrámek, Bojan Zarić, Ikuo Yamamiya, Karim A. Benhadji, K Hamada, Yaohua He, Lee S. Rosen	2021	6
15	Two Cases of Rare Pancreatic Malignancies SHILAP Revista de lepidopterología ·Wissam Hanayneh, Hiral D. Parekh, Garrett Fitzpatrick, Michael Feely, Thomas J. George, Jason S. Starr	2019	4
16	Human Pancreatic Cancer Cells Induce a MyD88-Dependent Stromal Response to Promote a Tumor-Tolerant Immune Microenvironment Cancer Research ·Daniel Delitto, Andrea E. Delitto, Bayli B. DiVita, Kien Pham, Song Han, Emily R. Hartlage, Brittney N. Newby, Michael H. Gerber, K.E. Behrns, Lyle L. Moldawer, Ryan M. Thomas, Thomas J. George, Todd M. Brusko, Clayton E. Mathews, Chen Liu, José G. Treviño, Steven J. Hughes, Shannon M. Wallet	2016	23
17	NRG GI002: Moving the needle toward TNT in locally advanced rectal cancer. PubMed ·Thomas J. George, Christina Wu, Y. Nancy You	2016	2
18	Nicotine Reduces Survival via Augmentation of Paracrine HGF–MET Signaling in the Pancreatic Cancer Microenvironment Clinical Cancer Research ·Daniel Delitto, Dongyu Zhang, Song Han, Brian S. Black, Andrea E. Knowlton, Adrian C. Vlada, George A. Sarosi, K.E. Behrns, Ryan M. Thomas, Xiaomin Lu, Chen Liu, Thomas J. George, Steven J. Hughes, Shannon M. Wallet, José G. Treviño	2015	31
19	Dissipation kinetics and effect of processing on imidacloprid and its metabolites in cardamom (Elettaria cardamomum Maton) Environmental Monitoring and Assessment ·N Pratheeshkumar, M. Chandran, S. Naseema Beevi, Thomas Biju Mathew, Thomas J. George, Ambily Paul, George Xavier, K Prathibha Ravi, S Visal Kumar, R. Rajith	2015	13
20	Small Molecule Inhibitor YM155-Mediated Activation of Death Receptor 5 Is Crucial for Chemotherapy-Induced Apoptosis in Pancreatic Carcinoma Molecular Cancer Therapeutics ·Xiangxuan Zhao, William Puszyk, Zaiming Lu, David A. Ostrov, Thomas J. George, Keith D. Robertson, Chen Liu	2014	19

About Thomas J. George

Thomas J. George is a scholar working on Oncology, Cancer Research, Pathology and Forensic Medicine, Finance and Hepatology, having authored 415 papers that have together received 7.4k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (89 papers), Pancreatic and Hepatic Oncology Research (53 papers), Genetic factors in colorectal cancer (53 papers), Cancer Genomics and Diagnostics (51 papers), Colorectal Cancer Surgical Treatments (46 papers), Colorectal and Anal Carcinomas (38 papers), Gastric Cancer Management and Outcomes (35 papers) and Financial Markets and Investment Strategies (31 papers). The work is most often cited by research in Finance (1.8k citations), Oncology (2.6k citations), Accounting (1.1k citations), Cancer Research (716 citations) and Economics and Econometrics (1.1k citations). Thomas J. George has collaborated with scholars based in United States, India and Canada. Frequent co-authors include Chuan-Yang Hwang, Mahendrarajah Nimalendran, Gautam Kaul, Carmen J. Allegra, Z. Hugh Fan, Jason S. Starr, Greg Yothers, Chen Liu, Atif Iqbal and Steven J. Hughes. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Organic Chemistry, Cancer Research, Cancer Medicine and The Oncologist.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact